<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03195361</url>
  </required_header>
  <id_info>
    <org_study_id>CD-14-011</org_study_id>
    <nct_id>NCT03195361</nct_id>
  </id_info>
  <brief_title>Multicenter, Prospective, Non-randomized, Single-arm, Interventional Study for the Evaluation of the Safety and Preformance of the SRS Device for the Treatment of Pelvic Organ Prolapse</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lyra Medical Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lyra Medical Ltd.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective, single arm, multi-center clinical study to evaluate the safety and performance
      of the SRS (Lyra Medical) vaginal mesh in POP patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The SRS implant is intended for transvaginal surgical treatment of anterior vaginal wall
      prolapse with or without vaginal apex/uterine prolapses
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 2016</start_date>
  <completion_date type="Anticipated">August 2020</completion_date>
  <primary_completion_date type="Anticipated">August 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement in POP-Q points Aa and Ba</measure>
    <time_frame>36 months</time_frame>
    <description>Points Aa and\or Ba are less than -1</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Improvement in POP-Q point C:</measure>
    <time_frame>36 months</time_frame>
    <description>Point C at -5 or less</description>
  </primary_outcome>
  <primary_outcome>
    <measure>No unexpected serious adverse device related events</measure>
    <time_frame>36 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Achieving normal urinary function:</measure>
    <time_frame>36 Months</time_frame>
    <description>Patient does not experience voiding dysfunction and have negative Urinary Cough Test.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement in Quality Of Life (QoL)</measure>
    <time_frame>36 Months</time_frame>
    <description>Subjective bother involving pelvic floor disorders using validated scales including PFDI-20 and PSIQ-12.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Anterior Vaginal Wall Prolapse With/Without Apical/Uterine Descent</condition>
  <arm_group>
    <arm_group_label>Single-arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects suffering from anterior POP-Q grade 2 (point Aa and Baâ‰¥ -1) and above, who are scheduled for POP surgery, will be transplanted with the SRS device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SRS - Self Retaining Support system</intervention_name>
    <arm_group_label>Single-arm</arm_group_label>
    <other_name>transvaginal surgical treatment</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient has signed the informed consent form and is willing to participate in the
             clinical study and data collection.

          2. Patient age is between 50 and 75 years old

          3. POP-Q: Aa and/or Ba is at least -1

        Exclusion Criteria:

          1. Patient is pregnant or breastfeeding

          2. Patient is suffering from active infection (on antibiotic therapy)

          3. Patient is planning vaginal delivery

          4. Patient had previous vaginal mesh surgery

          5. Patient is in high risk for surgery (evidence of clinically significant
             cardiovascular, renal, hepatic, coagulatory or respiratory diseases).

          6. Any condition that in the judgment of the investigators would interfere with the
             subject's ability to provide informed consent, comply with study instructions, place
             the subject at increased risk, or which might confound interpretation of study
             results.

          7. Malignancy.

          8. Known hypersensitivity to PEEK and/or polypropylene materials.

          9. Participation in another investigational trial that has not completed the primary
             endpoint or interferes with study participation.

         10. Diagnosed with mental or emotional disturbance.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Mayanei HaYeshua Medical Center</name>
      <address>
        <city>Bnei Brak</city>
        <zip>51544</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ziv Medical center</name>
      <address>
        <city>Safed</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asaf HaRofeh Medical Center</name>
      <address>
        <city>Zrifin</city>
        <zip>70300</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 1, 2016</study_first_submitted>
  <study_first_submitted_qc>June 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 22, 2017</study_first_posted>
  <last_update_submitted>March 6, 2018</last_update_submitted>
  <last_update_submitted_qc>March 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

